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II. Methodology
A. Clinical data acquisition
The clinical acquisition was approved by the ethical committee (Commission Centrale d' Éthique) of the University
Hospital of Geneva and agreed to by each participating patient.
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Clinical protocol
The clinical protocol included a flow measurement with Doppler ultrasound technique and two image data sets acquisition, which were acquired by a rotational X-ray system (Allura Xper FD20 system of Philips Healthcare). For the X-ray imaging, the dose levels did not exceed the standard clinical interventions.
Transcranial color coded Doppler (TCCD) measurements were performed shortly before image 95 acquisition. Thus, the patients' physiological blood flow velocity was measured without being disturbed by the CA injection. This data was used for calculating flow BCs for CFD simulation (cf. Sec. II. C).
Three-dimensional rotational angiograms (3DRA)
showing the complete cerebral vessel tree structure was acquired by a total CA (Iopamiro 300) injection of 21ml at an injection rate of 3ml/s. A total number of 120 images were generated for 210 degree rotation and a frame rate of 30fps. The 3DRA was used for 100 extracting the geometric model of the vessel of interest (cf. Sec. II. B).
Digital subtracted angiograms (DSA)
showed the flow sequence with CA. The injection of CA lasted three seconds with constant injection rates between 1ml/s and 2ml/s. The start of the DSA acquisition was triggered by the CA injection, which started at an R peak. The acquisition lasted six seconds at a frame rate of 90 or 150fps. The acquired DSA images which will be called AAs in the following were used for 105 extracting inflow BCs as well as being the ground truth for CFD evaluation (cf. Sec. II. C and Sec. II. F).
Since the CA injection disturbed the blood flow, extracting the TIC from where the flow mixing just started was important for subsequent BCs calculation and CFD simulation. Therefore, the CA injection catheter was required to be included in the DSA images whenever possible. However, due to the impossibility of a direct CA injection into the aneurysm and the limited detector size relative to the vessel structure, this requirement
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was not always satisfied.
Patient cases
Six patients were presented in this paper. Patient #1 had no visible aneurysm. Patient #2 to patient #6 were all diagnosed with saccular aneurysms. Patient #2 and patient #4 have developed symptoms with headache
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and diminished eye movement, respectively. The aneurysms caused no symptom for the rest of the patients and they were detected by undergoing other examinations. From patient #1 to patient #5, the CA injection 5 catheter tip was visible in the AAs, while for patient #6, the catheter tip was not included. The details of each patient case were summarized in Table I . 
B. Geometry modeling
To generate patient-specific volume meshes of the cerebral vessel structures which were suitable for CFD simulation,
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manual segmentation was first performed on the acquired 3DRA data to separate the vessel of interest from surrounding tissue. After that, a triangulated surface mesh was generated from the resulting bitmasks with Philips 6
proprietary software. The surface mesh was then refined using the Vascular Modeling Toolkit (VMTK). For it, nonshrinking filters were applied to the surface mesh to remove surface bumps caused by image segmentation, which might potentially result in spurious flow features [24, 25] . In order to increase the number of triangles, the surface 130 mesh was further subdivided by the Butterfly smooth subdivision scheme [26] . In addition, flat boundaries were created for each inlet and outlet perpendicular to the vessel 3D centerline [27, 28] . Next, unstructured volume mesh generation was performed by Netgen (version 4.5), which automatically generated smaller elements near the wall and larger elements in the center. The entire mesh generation process required about 2 hours. For patient #1 to patient #6, the generated meshes contained 200,000, 300,000, 230,000, 150,000, 210,000, and 180,000 tetrahedral elements, 
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C. Setting up patient-specific boundary conditions
Ideally, to simulate the CA propagation in a pulsatile blood flow, the required BCs were the vessel inlet flow velocity during the CA injection and the CA concentration over the vessel's inlet cross section. At the outlet, flow rate or pressure indicating different downstream resistances should be measured if flow division was involved.
However, instantaneous inlet flow measurement was difficult to achieve in the clinical work flow. Besides, at the 145 outlet, flow rates or pressure measurements were often not available. Therefore, in this study, two inlet BCs were calculated from the TCCD measurement and extracted from the AAs, which will be discussed in the following paragraphs. Traction free BCs were applied to the outflow boundaries. The vessel walls were assumed to be impermeable and rigid, and thus, no-slip wall conditions were applied [29] .
At the vessel inlet, due to the CA injection, the total flow Q TOT (t) was increased and can be considered as a 150 combination of two flow streams: the physiological blood flow Q B (t) as it went through the vessel without disturbance and the CA injection flow Q CA (t).
7
 Q B (t) was calculated from TCCD measurement. For it, the TCCD measured flow velocity was first averaged over the measured heart cycles and the flow rate was calculated with the vessel diameter. After that, the flow rate was extended to be a periodical flow Q B (t).
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 Q CA (t) was the CA injection flow from catheter. Due to the vessel compliance, Q TOT (t) was not a direct addition of Q B (t) and Q CA (t). Instead, a portion of Q CA (t) increased the Q TOT (t) and can be expressed as (1) 160 where m was a mixing factor which depended on the relation of the flow resistance downstream and upstream of the injection site. The mixing factor m was chosen to be 0.3, which has been shown to be a reasonable value [30] . 
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Next, the CA concentration C CA (t) in the mixed fluid at the vessel inlet needs to be expressed and calculated. If the CA injection catheter was present in the AAs (Fig. 2 (a) ), I CA (t) showing image intensity changing with time can be obtained by manually extracting a TIC from the catheter tip. I CA (t) was directly related to the CA concentration.
Additional scaling was needed to be applied on I CA (t) to represent the actual value of the CA concentration:
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where k was the scaling factor between I CA (t) and C CA (t). Besides, we assumed that the C CA (t), Q CA (t) and Q TOT (t) had the following relationship 180
Since the mean value of Q CA (t) was known from the clinical settings, all variables in Eq. 1-Eq. 3 can be determined.
For some patient cases, the catheter tip was not present in the field of view (FOV), thus making the extraction of Fig. 2 (b) ). Moreover, in some cases, the injection site was far away, and the flow may undergo 185 divisions, diffusions, etc., which can strongly change the shape of the TIC curve. Therefore, the TIC extracted in the AAs even from the most upstream region may not be suitable for deriving the values of C CA (t). Therefore, Q TOT (t) and Q CA (t) cannot be directly calculated with the available measurements and acquisitions. Due to the resistance and capacity of the catheter, the CA injection was considered as a lumped model for a combination of a capacitance and a resistance, resulting in the Q CA (t) with a shape of an electrical charging curve
where ̂ was the maximum CA injection rate, T s was the start time of the injection, T L was the characteristic lag time, and T D was the injection duration [31] . Q TOT (t) was then calculated with the modeled Q CA (t) and the periodic Q B (t)
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using Eq. 1. After that, the CA concentration C CA (t) was represented by the ratio of the Q CA (t) and the resulting Q TOT (t) using Eq. 3.
Next, the velocity of Q TOT (t) was calculated by the Womersley solution [32] [33] [34] and imposed at the vessel inlet.
The CA was assumed to be homogeneously mixed with the blood at the injection site, and therefore, C CA (t) was uniformly mapped onto the vessel inlet.
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D. Flow modeling with CFD
The open source software Field Operation and Manipulation (OpenFOAM version 1.6) was used for numerical flow simulation. The simulation involved a twofold procedure consisting of blood flow modeling and CA transport. The simulation time was around 58 hours in average.
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Flow simulation
In this work, the blood flow was assumed to have Newtonian fluid properties. In all patient cases, the Reynolds number Re was estimated before the simulation for the entire spatial domain to ensure non-turbulent flow [35] . The dynamics of blood flow through the vessel were then calculated by the non-steady 3D Navier-Stokes equations
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consisting of the continuity equation (Eq. 5) and the momentum equation (Eq. 6):
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where V was the flow velocity, t was the time and p was the pressure. ρ was the blood density which was set to 1,050kg· m -3 and μ was the dynamic viscosity of blood which was set to 3.5 10 -3 kg· m -1 · s -1 in order to approximate the physical properties of blood.
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Contrast agent simulation
The injection of the CA within the blood can be thought of as a multi-fluid problem. Solving such problems required coupling the solving of the equations of these two fluid phases. However, the CA was commonly assumed to have the same characteristics as blood, notably in terms of blood viscosity. As a result, the CA propagation can be modeled as a passive transport of particles within the blood, which was an advection and diffusion process. The advection was
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caused by the movement of the fluid, whereas the diffusion was the motion due to the concentration differences. This can be modeled by the following advection-diffusion equation (7) 230 where V was the computed velocity field from the previous calculation step, C was the scalar field of the CA concentration and κ was the diffusion coefficient, which was set to 10 -6 m 2 · s -1 in this study [21] .
E. Virtual angiogram generation
The Philips proprietary software Radonis (Philips Research, Hamburg, Germany) was used to generate virtual 235 angiograms (VAs). First, the output mesh from CFD simulation with CA stored in each element was transformed into a voxelised volume. Second, attenuation was calculated based on the iodine concentration in the CA in each voxel.
After that, the X-ray spectrum, the current and the radiation time were specified to match the real X-ray system configurations. The tube and the detector positions relative to the created volume were set to obtain a similar orientation as the acquired projections. Based on Lambert-Beer's law, Radonis simulated the number of detected 240 photons for each detector pixel after the X-ray beam passed an object. As a result, for each time instance, an X-ray projection was virtually generated. Additionally, a mask image was generated before the CA was injected. Realistic
VAs correspondent to the AAs were obtained by subtracting the mask image from the CA opacified images after they were logarithmically transformed.
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F. Qualitative and quantitative methods for CFD validation
In order to thoroughly validate the CFD results, we utilized the spatial and temporal information of the CA. This information formed the basis for direct comparison between the AAs and the VAs. The correspondence between the AAs and the VAs should be assessed in detail for different crucial flow parameters. For example, BAT, which was the time instance of CA arriving at a specific region, can be computed for both angiograms and compared. In the clinics,
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the BAT was considered as a crucial factor indicating neuro-vascular diseases by comparing the difference between the corresponding vessel sections in the left and right hemisphere [36] . Besides, the differences between the maximum and minimum values of cerebral blood flow during cardiac cycles can be quantified by flow pulsatility. The flow pulsatility varied for different vessel sections and can be influenced by clinical interventions [37, 38] . It played an important role in the behavior of the blood flow inside the aneurysms [13] . Peak-to-peak interval was the time period
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between maximum CA concentration at a specific region for multiple heart cycles. This can be used to indicate blood flow speed at different vessel sections. Precisely capturing these parameters in the CFD simulation indicated that the simulated flow strongly mimicked the real flow dynamics, which increased level of reliability for CFD results.
Qualitative CFD validation method
260
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Qualitative comparisons were performed first by visual inspection of the AAs and the VAs at different time instances.
Both angiograms were displayed in grayscale with range 0-255 using ImageJ. Such a macroscopic comparison was able to capture information such as rough CA propagation sequences, without the need for any further computation.
Quantitative CFD validation method
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To evaluate the correspondence of the flow parameters in detail, quantitative measures were defined. For cases in which the vessel structures were without an aneurysm, no local complex flow or associated secondary velocity vortices were expected to appear. Therefore, it was believed that the flow along the centerline can adequately represent the overall flow dynamics. Thus, a flow map can be generated as an image, where the pixel intensity was proportional to the iodine concentration, as illustrated in Fig. 3 (a, middle) . To this end, the 3D vessel centerline was 270 first extracted. By projecting the 3D centerline onto the 2D angiograms, the vessel foreshortening was taken into account in the 2D projection plane. In the flow map, the horizontal axis was for time and the vertical axis was for length along the vessel centerline. The rows of the flow map corresponded to the TICs, as shown in Fig. 3 (a, right) .
Flow maps allowed the analysis of the image intensity variations with respect to time and distance along the vessel centerline. Moreover, in cases where a localized comparison was required, TICs can be extracted comparing directly 275 the variation of the CA at a defined location. These provided a good validation basis as it not only provided information regarding when CA reached a particular location, it also showed how the CA concentration varied temporally, which was more relevant particularly with a pulsatile pattern.
In the cases where an aneurysm was present in the investigated cerebral vasculature, the flow in the aneurysm region was of most importance and interest. Particularly, it was suggested that the flow pattern close to the aneurysm
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wall played an important role in potential aneurysm rupture [1, 3, 39, 40] . angiogram sequences over all the examined ROIs was computed. Besides, the averaged difference of pulsatility and peak-to-peak interval for the identified cycles was quantified in relative to the TICs extracted from AAs. The overall 300 deviations between the TICs were further calculated as the relative root mean square error (rRMSE)
where n was the number of data points in a TIC, P i was the value at a certain time instance of the simulated TIC, T i 305 was the value of the correspondingly acquired TIC from the clinics, and T M was the mean value of each acquired TIC from the clinics. 
III. Results
2D
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IV. Discussion
The evaluation result1s for patient #3 were exemplarily examined in detail. For this case, the velocity streamlines were shown in Fig. 4 Besides, the CA diffusion had much stronger effect at these positions, resulting in a trend of decreased flow pulsatility. Although at these positions, the general flow patterns were well predicted by the TICs from the VAs, certain deviations did exist. The TICs from the VAs were flatter than those from the AAs. Besides, at the washout phase which was the time period shortly before 4.00s, the TICs from the AAs showed more rapid intensity decrement compared to that from the VAs, and this was more prominent at the ROI position E. At the ROI position F, the flow 19 pulsatility was observed to be stronger than that of other positions in the aneurysm. This was because at this position, flow with strong pulsatility from upstream parent vessel and flow with decreased pulsatility from the aneurysm were mixed, resulting in a medium flow pulsatility. This can be also reflected by the fact that the bolus arrived earlier at the ROI position F than C, confirming that a considerable part of the CA was directly transported to the downstream parent vessel. In comparison, the flow characteristics corresponded well between TICs from the AAs and the VAs.
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For patient #3 and all the other patient cases, major flow characteristics and correspondence between the AAs and VAs were summarized in Table II . 
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As we can see from Fig. 4 and Table II (Velocity streamline visualization), for the patient cases with aneurysms, certain common characteristics of the flow patterns were observed from the velocity streamlines. First, the blood flow velocity was significantly reduced inside the aneurysm region compared to that in the parent vessels. Second, the blood flow circulated within the aneurysm and formed a single vortex structure. However, it was also found that the aneurysm inflow impaction zones, the direction of flow circulation and the orientation of the vortices varied from case 425 to case were strongly depending on the aneurysm morphologies.
From Fig. 5 and Table II 
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BCs were mostly based on assumptions. This was probably because for the pulsatile blood flow, the pressure at any location varied from time to time. At the catheter tip, the CA injection was disturbed by the varying pressure. Thus, it was not exactly represented by the assumed lumped model.
For all the cases studied, the remaining discrepancies may be caused by one or more of the following simplifications made during the modeling process pipeline.
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 First, a major observation for all the TIC comparisons was the local fluctuations of the TICs from the AAs, which were not captured by the TICs from the VAs. These fluctuations could be caused by the non-uniform CA injection resulting in streamlines. Besides, in the real scenario, the image subtraction process for DSA creation increased the noise in the resulting AAs due to the random noise distribution in both mask and original contrasted images. In the process of generating VAs, the vessel model was completely rigid and 460 stable, the non-uniform CA injection and the noise in AAs were not present, hence ideal and smooth TICs were produced.
 Second, the CA disturbed volumetric flow rates used for CFD simulations were calculated based on the assumption that the physiological blood flow was increased by a fixed fraction m=0.3 of the CA flow Q CA (t).
Depending on the patient's individual vessel resistances, this value might be slightly higher or lower, leading
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to a different Q TOT (t). Therefore, the blood velocity may be under or overestimated and the flow pulsatility may be deviated from the actual scenario.
 Third, the physiological blood flow used for CFD simulation was calculated from the blood velocity measured by TCCD using an estimated vessel radius from 3DRA. This can potentially cause inaccuracies because the TCCD measurement location was not exactly known, and hence, the vessel radius might be 470 slightly over-or underestimated. Besides, although TCCD was currently the preferred non-invasive measurement method, it had an intrinsic error which can cause up to 30% inaccuracy [42] . This may induce deviations between the CFD calculated and real blood flow, and thus, the transport of the CA.
 Fourth, in the CFD simulations, the averaged flow rate from subsequent cardiac cycles was used to represent the periodic blood flow. However, blood flow was not entirely periodic with small variations in each cycle,
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and thus, the periodic flow assumption may lead to possible deviations.
 Fifth, the acquired 3DRA images contained large amount of data besides the vessel of interest such as surrounding tissue and connecting vessels, which deteriorated the image quality and made an accurate vessel segmentation and reconstruction difficult. This may induce additional errors in the computed flow fields.
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V. Conclusion
In this paper, we have demonstrated that the CFD simulation for predicting blood flow in the cerebral vessels and aneurysms can match clinical acquisitions with good accuracy. Comprehensive CFD validation was performed on six patient cases, with patient-specifically measured flow BCs. It was also shown that accurate input BCs helped to improve the reliability of the simulation results. A fully validated CFD had great potential to make a significant 485 contribution for deepening the knowledge of the hemodynamics in the cerebral vasculature and leading to a new understanding of the formation and the rupture of the aneurysms.
In future, this work will be extended to the CFD validation of aneurismal blood flow with endovascular treatment such as stent placement. This will enable a reliable pre-operative evaluation and help to ensure the operation efficacy.
